Maintenance Immunosuppression

Maintenance Immunosuppression is a long-term pharmacotherapeutic regimen in solid-organ transplantation that entails sustained, usually combination, administration of immunosuppressive agents at relatively stable doses to prevent acute and chronic allograft rejection while minimizing drug-related toxicity after the initial post-transplant period.

3.3K

Publications

180.4K

Citations

17K

Authors

2.8K

Institutions

Publications per year

2017–2026

467

Authors

17K

  1. KB
    Klemens Budde

    Charité - Universitätsmedizin Berlin, Germany

    50 publications · 3.2K citations

    29

    h-index

  2. FV
    Flavio Vincenti

    University of California, San Francisco, United States

    35 publications · 4.3K citations

    27

    h-index

  3. LR
    Lionel Rostaing

    Hôpital Rangueil, France

    34 publications · 3.3K citations

    24

    h-index

  4. GW
    George W. Burke

    University of Miami, United States

    34 publications · 2.2K citations

    22

    h-index

  5. JM
    Josep M. Campistol

    Hospital Clínic de Barcelona, Spain

    26 publications · 2.1K citations

    20

    h-index

1–5 of 17K

Venues

  1. Transplantation

    526 publications · 36.6K citations

    101

    h-index

  2. American Journal of Transplantation

    203 publications · 19.9K citations

    82

    h-index

  3. PubMed

    Repository · 303 publications · 10.1K citations

    51

    h-index

  4. Blood

    72 publications · 5.3K citations

    39

    h-index

  5. Clinical Transplantation

    159 publications · 5.7K citations

    39

    h-index

1–5